Advanced brachytherapy dosimetric considerations

The practice of brachytherapy and brachytherapy dosimetry was investigated with emphasis on evaluations of dose distributions and shielding considerations for both photon- and neutron-emitting radionuclides. Monte Carlo simulation methods were employed to calculate dose distributions for virtual and commercial brachytherapy sources. Radionuclides studied were 103Pd, 1251, 131Cs, 137Cs, 169b, 192Ir, and 252Cf. 252Cf sources also emit neutrons from spontaneous fission. The brachytherapy dosimetry protocol recommended by the American Association of Physicists in Medicine was followed and evaluated for conditions of partial scatter (non-infinite media) and material inhomogeneities, both commonly encountered in brachytherapy treatment. Furthermore, energy-dependent characteristics of dosimetry parameters were evaluated and reference calculations performed for virtual photon and neutron sources. These findings were applied to three clinical brachytherapy cases: eye plaques using 103Pd, 125I, and 131Cs; high-dose rate 252Cf treatment; and, 2 Cf plaques for superficial lesions. For eye plaques, material heterogeneities were significant for each radionuclide with dose reduction at 5 mm of 18%, 11%, and 10% for P03pd, 125I, and 131Cs, respectively. For a proposed highdose rate 252Cf source (5mm length), relative brachytherapy dosimetry parameters were found to be similar to those obtained for a low-dose rate Applicator Tube-type source (15 mm length). Considering 252Cf plaque brachytherapy when partial scatter conditions were accounted for, central axis equivalent dose rate decreased by 11 ± 1% and 7 ± 2% for depths of 4 to 50 mm, respectively.

Department dc:contributor.department

Harvard University--MIT Division of Health Sciences and Technology.

Grantor dc:publisher

Massachusetts Institute of Technology

Year dc:date.issued

2008

Author dc:creator

• Melhus, Christopher S. (Christopher Scott), 1974-

Advisor dc:contributor.advisor

• Mark J. Rivard.

• Harvard University--MIT Division of Health Sciences and Technology.

Statement dc:rights

• M.I.T. theses are protected by copyright. They may be viewed from this source for any purpose, but reproduction or distribution in any format is prohibited without written permission. See provided URL for inquiries about permission.

Licence dc:rights.uri

• http://dspace.mit.edu/handle/1721.1/7582

Language dc:language.iso

eng

Handle dc:identifier.uri

http://hdl.handle.net/1721.1/43808

OAI identifier oai:identifier

oai:dspace.mit.edu:1721.1/43808